Pricing Log in Create free account

Krystal Biotech, Inc. (KRYS) vs Bio-Techne Corp (TECH)

Krystal Biotech, Inc. and Bio-Techne Corp are both Biotechnology companies. Bio-Techne Corp is the larger, with a market value of $11.4B against $9.8B — 1.2× the size. Krystal Biotech, Inc. trades at the lower P/E: 38.3× against 62.0×. Krystal Biotech, Inc. grew revenue faster over the last twelve months: 22.6% against −0.38%. Krystal Biotech, Inc. has the higher net margin (54.8% vs 15.0%) and the higher return on invested capital (24.1% vs 7.70%). Across the 21 metrics below, Krystal Biotech, Inc. leads on 15 and Bio-Techne Corp on 6.

Valuation

Metric KRYS TECH Biotechnology median
P/E 38.28 62.00 8.50
P/S 21.22 9.31 9.71
P/B 6.88 5.37 2.13
Price to free cash flow 36.26 42.98 20.82
EV/EBITDA 41.59 32.24 0.64
EV/Sales 19.30 9.27 9.21
Earnings yield 2.61% 1.61% (33.15%)
Free cash flow yield 2.76% 2.33% (25.50%)

Profitability

Metric KRYS TECH Biotechnology median
Gross margin 94.64% 65.77% 65.16%
Operating margin 44.89% 20.73% 0.00%
Net margin 54.82% 14.97% 0.00%
Free cash flow margin 58.52% 21.66% 0.00%
Return on equity 20.12% 9.03% (56.36%)
Return on assets 18.30% 7.07% (48.04%)
Return on invested capital 24.07% 7.70% 0.00%

Growth

Metric KRYS TECH Biotechnology median
Revenue growth (TTM) 22.63% (0.38%) 6.02%
EPS growth (last fiscal year) 128.00% 152.17% 30.26%
Revenue growth, 5-year CAGR — 5.47% 9.41%
Net income growth, 5-year CAGR 0.00% 5.31% 0.00%

Health

Metric KRYS TECH Biotechnology median
Debt to equity 0.00 0.09 0.00
Current ratio 8.32 4.55 4.72
Net debt to EBITDA (4.93) (0.19) 0.96

Dividend

Metric KRYS TECH Biotechnology median
Dividend yield — 0.44% 0.09%
Payout ratio — 0.28 —

Size

Metric KRYS TECH Biotechnology median
Market cap 9.77b 11.37b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack